Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q1 2021 Earnings

24FebConfirmed

Q2 2020

Q3 2020

Q4 2020

Q1 2021

-0.57

-0.47

-0.37

-0.27

Details

Expected EPS

-0.48

Actual EPS

-0.42

Surprise EPS

0.06

Surprise Percent

+12.5%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.42 per share for Q1 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.